悦康药业：申请H股发行并赴港上市同步刊登申请资料

Core Viewpoint - The company, Yuyuan Pharmaceutical Group Co., Ltd., has submitted an application for the issuance of overseas listed foreign shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange [1] Group 1: Company Actions - The application was submitted on December 29, 2025, to the Hong Kong Stock Exchange [1] - The application materials were published on the Hong Kong Stock Exchange website on the same day [1] - The materials were prepared in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange [1] Group 2: Investor Guidance - The published application materials are in draft form and may be updated or revised [1] - Investors are advised not to make any investment decisions based solely on the information contained in the application materials [1]